GW Pharma soars as cannabis drug succeeds in epilepsy trial
 

GW Pharma soars as cannabis drug succeeds in epilepsy trial
LONDON (Reuters) - An experimental cannabis-based drug has successfully treated children with a rare form of severe epilepsy in a keenly anticipated clinical trial, sending shares in its maker GW Pharmaceuticals 68 percent higher on Monday.


http://rc.feedsportal.com/r/24739459...38/rc/1/rc.img

http://rc.feedsportal.com/r/24739459...38/rc/2/rc.img

http://rc.feedsportal.com/r/24739459...38/rc/3/rc.img

http://da.feedsportal.com/r/24739459...6/sc/38/a2.img
http://adchoice.feedsportal.com/r/24.../sc/38/ach.imghttp://pi.feedsportal.com/r/24739459.../sc/38/a2t.imghttp://pi2.feedsportal.com/r/2473945...sc/38/a2t2.imghttp://i0.wp.com/reuters.us.feedspor...f?resize=1%2C1http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...A8:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...A8:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/UsA520CDDzM